EIF4EBP1 and head and neck squamous cell carcinoma: An overactive AKT-mTOR pathway, reduced expression of 4EBP1, upregulated eIF2 inhibitory kinases, and increased expression of eIF2A in HNSCC patients correlate with poor patient prognosis and it suggests that redirection to non-canonical initiation renders tumors refractory to treatment.